BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23260709)

  • 1. Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation.
    Xu Y; Galambos C; Reyes-Múgica M; Miller SA; Zeevi A; Webber SA; Feingold B
    J Heart Lung Transplant; 2013 Jan; 32(1):92-7. PubMed ID: 23260709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
    Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
    Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
    Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
    J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
    Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
    Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients.
    Gupta S; Mitchell JD; Lavingia B; Ewing GE; Feliciano MN; Kaiser PA; Ring WS; Stastny P; Patel PC; Markham DW; Mammen PP; Dimaio JM; Drazner MH
    J Heart Lung Transplant; 2009 Aug; 28(8):776-80. PubMed ID: 19632572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte globulin induction therapy and myocardial complement deposition in pediatric heart transplantation.
    Ghaleb S; Wittekind SG; Martinez H; Kasten J; Gao Z; Hengehold T; Chin C
    Pediatr Transplant; 2021 Sep; 25(6):e13998. PubMed ID: 33704881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?
    Peng DM; Law YM; Kemna MS; Warner P; Nelson K; Boucek RJ
    Pediatr Transplant; 2013 Aug; 17(5):429-35. PubMed ID: 23551503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.
    Holt DB; Liapis H; Mohanakumar T; Phelan DR; Gandi SK; Huddleston CB; Canter CE
    J Heart Lung Transplant; 2008 Oct; 27(10):1073-8. PubMed ID: 18926396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection.
    Fedrigo M; Feltrin G; Poli F; Frigo AC; Benazzi E; Gambino A; Tona F; Caforio AL; Castellani C; Toscano G; Gerosa G; Thiene G; Angelini A
    J Heart Lung Transplant; 2013 Apr; 32(4):404-9. PubMed ID: 23498161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
    Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
    Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E
    Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
    Mohamedali B; Pyle J; Bhat G
    Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
    Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
    Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of c4d immunostaining utilizing paraffin-embedded tissue of nonpresensitized pediatric heart transplant patients.
    Galambos C; Feingold B; Webber SA
    Pediatr Dev Pathol; 2008; 11(3):181-4. PubMed ID: 17990923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation.
    Smith JD; Hamour IM; Banner NR; Rose ML
    Am J Transplant; 2007 Dec; 7(12):2809-15. PubMed ID: 17908268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function?
    Frea S; Iacovino C; Botta M; De Filippi I; Mazzucco G; Pidello S; Biolè C; Bergerone S; Boffini M; Praticò Barbato L; Morello M; Rinaldi M; Gaita F
    Clin Transplant; 2016 Oct; 30(10):1314-1323. PubMed ID: 27490635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
    Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
    Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.